What this study is
The goal of this randomized study is to assess if a conversational agent (or chatbot) that the investigators have developed to help with quitting smoking is acceptable to people trying to quit smoking and to also collect initial information regarding its effectiveness.
In this study, some participants trying to quit smoking will be provided with this chatbot while other participants will not be
What's being tested
- chatbot
Intervention · OTHER
a chatbot will alert during predicted high risk smoking times and suggest approaches to manage potential smoking triggers
- no chatbot
Intervention · OTHER
no chatbot is provided
Study details
- Official title
- Feasibility of Using a Conversational Agent for Promoting Smoking Cessation Treatment Utilization
- Sponsor
- University of Minnesota
- Conditions
- Smoking Cessation · Smoking (Tobacco) Addiction
- Enrolling
- 120 people
- Starts
- 2026-06-11
- Est. completion
- 2027-06-30
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 21 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Identify as Black or African American
- Be at least 21 years of age
- Meet a minimum smoking amount
- Be willing to make a quit attempt in the next 30 days
- Have a smartphone capable of downloading and running the study app
- Be able to upload data from the app
- Agree to receive text message reminders about study activities
- Be a native English speaker
- Reside in Minnesota.
You can't join if
- Medicinal nicotine use would require careful monitoring by a healthcare professional
- Medical condition or medication used likely to significantly interfere with study outcomes or to be significantly affected by changes in smoking behavior
- Are pregnant or breastfeeding
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Minnesota
Minneapolis, Minnesota, United States
Recruiting
Study team
Sponsor
University of Minnesota
Study ID STUDY00026782
Principal investigator
Michael Kotlyar
University of Minnesota
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.